Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-261640

Options or other derivatives

  • Director acquired 24,372 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Quimi Daphne · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-04 Grant or award : show line 1 in the form Stock Option (right to buy) +24,372 24,372 D
Loading xslF345X06/ownership.xml…